Related Experiment Video
Updated: Jan 9, 2026

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Speech pause and speech rate for evaluating Alzheimer's and mild cognitive impairment: A meta-analysis
Alex S Cohen1, Ross Divers1, Matthew Calamia2
1Department of Psychology, https://ror.org/05ect4e57Louisiana State University, Baton Rouge, LA, USA.
Objective:
Evaluating pauses in natural speech is a promising strategy for improving reliability, validity, and efficiency in assessing cognitive functions in people with mild cognitive impairment (MCI) and Alzheimer's dementia (AD).
Method:
We conducted a quantitative meta-analysis of studies employing automated pause analysis. We included measures of speaking rate for comparison.
Results:
We identified 13 studies evaluating pause measures and 8 studies of speaking rate in people with MCI (n's = 276 & 109, respectively) and AD (n's = 170 & 81, respectively) and healthy aged controls (n's = 492 & 231, respectively). Studies evaluated speech across various tasks, including standard neuropsychological, reading, and free/conversational tasks. People with AD and MCI showed longer pauses than controls at approximately 1.20 and 0.62 standard deviations, respectively, though there was substantial heterogeneity across studies. A more modest effect, of 0.66 and 0.27 SDs, was observed between these groups in speech rate. The largest effects were observed for standardized memory tasks.
Conclusions:
Of the many ways that speech can be objectified, pauses appear particularly important for understanding cognition in AD. Pause analysis has the benefit of being face valid, interpretable in ratio format as a reaction time, tied to known socio-cognitive functions, and relatively easy to measure, compute, and interpret. Automation of speech analysis can greatly expand the assessment of AD and potentially improve early identification of one of the most devastating and costly diseases affecting humans.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Dementia
The progression of dementia is generally gradual....
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

